BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32830024)

  • 1. Tumor necrosis factor-α inhibitor use for treatment of refractory cardiac sarcoidosis in a patient with left ventricular assist device: Adalimumab use in refractory sarcoidosis in a patient with left ventricular assist device.
    Krishnan M; Cupps TR; Sheikh FH
    J Heart Lung Transplant; 2020 Dec; 39(12):1504-1505. PubMed ID: 32830024
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac transplantation for cardiac sarcoidosis with initial diagnosis by examination of the left ventricular apical "core" excised for insertion of a left ventricular assist device for severe chronic heart failure.
    Roberts WC; Vowels TJ; Ko JM; Capehart JE; Hall SA
    Am J Cardiol; 2009 Jan; 103(1):110-4. PubMed ID: 19101239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Sarcoidosis.
    Birnie DH
    Semin Respir Crit Care Med; 2020 Oct; 41(5):626-640. PubMed ID: 32593175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac sarcoidosis.
    Zipse MM; Sauer WH
    Curr Cardiol Rep; 2014 Aug; 16(8):514. PubMed ID: 24969032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres.
    Fussner LA; Karlstedt E; Hodge DO; Fine NM; Kalra S; Carmona EM; Utz JP; Isaac DL; Cooper LT
    Eur J Heart Fail; 2018 Dec; 20(12):1713-1720. PubMed ID: 30378224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circumventing a left ventricular assist device and implantable cardioverter defibrillator interaction: an alternative method of shielding.
    Guise KD; Franconame F; Chung EH
    Europace; 2013 Dec; 15(12):1689. PubMed ID: 23608031
    [No Abstract]   [Full Text] [Related]  

  • 7. The vortex of three-dimensional mapping with a centrifugal ventricular assist device.
    Willcox M; Rane S; Mahr C; Beckman J; Mokadam N; Akoum N
    Europace; 2017 Mar; 19(3):457. PubMed ID: 27733473
    [No Abstract]   [Full Text] [Related]  

  • 8. Unusual Incessant Ventricular Tachycardia: What Is the Underlying Cause and the Possible Mechanism?
    Shenthar J
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1507-11. PubMed ID: 26671936
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis and management of cardiac sarcoidosis.
    Dubrey SW; Falk RH
    Prog Cardiovasc Dis; 2010; 52(4):336-46. PubMed ID: 20109603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous-flow left ventricular assist device implantation in the presence of a hostile ventricular apex.
    Atluri P; Dymond DJ; Woo YJ
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):981-2. PubMed ID: 23953985
    [No Abstract]   [Full Text] [Related]  

  • 11. Undiagnosed Cardiac Sarcoidosis Causing Refractory Heart Failure After Acute Myocardial Infarction due to Thromboembolism.
    Kai T; Ono Y; Matsushima S; Shinohara K; Nakashima R; Kawahara T; Katsuki M; Fujino T; Hashimoto T; Higo T; Tsutsui H
    Int Heart J; 2021 Mar; 62(2):437-440. PubMed ID: 33731532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiac sarcoidosis associated with heart failure].
    Otsuka K; Terasaki F; Kitaura Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():446-50. PubMed ID: 17569323
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac manifestations of sarcoidosis: diagnosis and management.
    Birnie DH; Kandolin R; Nery PB; Kupari M
    Eur Heart J; 2017 Sep; 38(35):2663-2670. PubMed ID: 27469375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac sarcoidosis: a potentially fatal but treatable form of infiltrative heart disease.
    Chau EM; Fan KY; Chow WH
    Hong Kong Med J; 2006 Feb; 12(1):65-7. PubMed ID: 16495592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adalimumab for the treatment of cardiac sarcoidosis with multiple arrhythmias.
    Li S; Wang H; Liu T; Li Q; Yang X; Xiong R; Lv Q; Du X; Dong J; Ma C
    ESC Heart Fail; 2022 Dec; 9(6):4325-4329. PubMed ID: 36043423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities.
    Soejima K; Yada H
    J Cardiovasc Electrophysiol; 2009 May; 20(5):578-83. PubMed ID: 19175448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac sarcoidosis: an uncommon presentation of sarcoidosis in India.
    Guleria R; Sharma R; Mohan A; Das C
    Indian J Chest Dis Allied Sci; 2006; 48(2):133-7. PubMed ID: 16696528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using TNF-alpha antagonist adalimumab for treatment for multisystem sarcoidosis: a case study.
    Lahmer T; Knopf A; Lanzl I; Heemann U; Thuermel K
    Rheumatol Int; 2012 Aug; 32(8):2367-70. PubMed ID: 21644042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentation, management and prognosis of patients with cardiac sarcoidosis.
    Ghanizada M; Rossing K; Bundgaard H; Gustafsson F
    Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dramatic presentation of cardiac sarcoidosis.
    Brown AJ; McCormick LM; Agrawal SK; De Bono J
    QJM; 2012 Mar; 105(3):269-71. PubMed ID: 21357613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.